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BACKGROUND: Adrenomedullin (ADM) regulates vascular tone and endothelial
permeability during sepsis. Levels of circulating biologically active ADM (bio-ADM)
show an inverse relationship with blood pressure and a direct relationship with
vasopressor requirement. In the present prospective observational multinational
Adrenomedullin and Outcome in Sepsis and Septic Shock 1 (, AdrenOSS-1) study, we
assessed relationships between circulating bio-ADM during the initial intensive care
unit (ICU) stay and short-term outcome in order to eventually design a biomarker-
guided randomized controlled trial.
METHODS: AdrenOSS-1 was a prospective observational multinational study. The
primary outcome was 28-day mortality. Secondary outcomes included organ failure as
defined by Sequential Organ Failure Assessment (SOFA) score, organ support with
focus on vasopressor/inotropic use, and need for renal replacement therapy.
AdrenOSS-1 included 583 patients admitted to the ICU with sepsis or septic shock.
RESULTS: Circulating bio-ADM levels were measured upon admission and at day 2.
Median bio-ADM concentration upon admission was 80.5 pg/ml [IQR 41.5-148.1
pg/ml]. Initial SOFA score was 7 [IQR 5-10], and 28-day mortality was 22%. We found
marked associations between bio-ADM upon admission and 28-day mortality
(unadjusted standardized HR 2.3 [CI 1.9-2.9]; adjusted HR 1.6 [CI 1.1-2.5]) and
between bio-ADM levels and SOFA score (p < 0.0001). Need of vasopressor/inotrope,
renal replacement therapy, and positive fluid balance were more prevalent in patients
with a bio-ADM > 70 pg/ml upon admission than in those with bio-ADM ≤ 70 pg/ml. In
patients with bio-ADM > 70 pg/ml upon admission, decrease in bio-ADM below 70
pg/ml at day 2 was associated with recovery of organ function at day 7 and better 28-
day outcome (9.5% mortality). By contrast, persistently elevated bio-ADM at day 2 was
associated with prolonged organ dysfunction and high 28-day mortality (38.1%
mortality, HR 4.9, 95% CI 2.5-9.8).
CONCLUSIONS: AdrenOSS-1 shows that early levels and rapid changes in bio-ADM
estimate short-term outcome in sepsis and septic shock. These data are the backbone
of the design of the biomarker-guided AdrenOSS-2 trial.
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